The current institutional shareholding score of WAVE Life Sciences Ltd is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 77.83%, representing a quarter-over-quarter decrease of 16.89%. The largest institutional shareholder is Lee Ainslie, holding a total of 11.62M shares, representing 5.28% of shares outstanding, with 0.02% decrease in holdings.